Date published: 2025-9-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

CWF19L1 Activators

CWF19L1 is a protein involved in cell cycle control, and its activity can be modulated through various biochemical pathways. Chemical activators such as those that increase intracellular cyclic AMP (cAMP) levels are known to influence the function of CWF19L1. For example, compounds that activate adenylate cyclase lead to an elevation of cAMP, which in turn can enhance CWF19L1 activity through protein kinase A (PKA)-dependent pathways that are essential for the regulation of the cell cycle. Similarly, beta-adrenergic receptor agonists also raise cAMP levels, potentially augmenting the activity of CWF19L1 via similar cAMP-dependent signaling mechanisms. Additionally, the use of phosphodiesterase inhibitors prevents the breakdown of cAMP, sustaining its cellular concentration and thereby potentially increasing CWF19L1's role in cell cycle control.

Other signaling molecules also play a substantial role in modulating the activity of CWF19L1. Activation of protein kinase C through certain diacylglycerol analogs may increase CWF19L1 activity as part of downstream signaling involved in cell cycle progression. Calcium ionophores, which elevate intracellular calcium levels, can also activate CWF19L1 indirectly by stimulating calcineurin and other calcium-dependent kinases that are implicated in cell cycle control. Furthermore, compounds that donate nitric oxide can activate cGMP pathways, which in turn may influence CWF19L1 activity, potentially linking it to cell cycle control mechanisms that are dependent on cGMP signaling.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$76.00
$150.00
$725.00
$1385.00
$2050.00
73
(3)

Activates adenylate cyclase, increasing cAMP levels. Higher cAMP enhances CWF19L1 activity as it can influence cell cycle control through PKA-dependent pathways.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$40.00
$129.00
$210.00
$490.00
$929.00
119
(6)

Activates protein kinase C (PKC), which can modulate cell cycle progression and may increase CWF19L1 activity as part of downstream signaling.

Ionomycin

56092-82-1sc-3592
sc-3592A
1 mg
5 mg
$76.00
$265.00
80
(4)

Increases intracellular calcium, activating calcineurin and other calcium-dependent kinases that could enhance CWF19L1 function in calcium signaling.

Isoproterenol Hydrochloride

51-30-9sc-202188
sc-202188A
100 mg
500 mg
$27.00
$37.00
5
(0)

Beta-adrenergic receptor agonist that raises cAMP levels, potentially augmenting CWF19L1 activity via cAMP-dependent signaling pathways.

(±)-S-Nitroso-N-acetylpenicillamine

79032-48-7sc-200319B
sc-200319
sc-200319A
10 mg
20 mg
100 mg
$73.00
$112.00
$367.00
18
(3)

Nitric oxide donor that can activate cGMP pathways, potentially influencing CWF19L1 activity as it may play a role in cell cycle control mechanisms linked to cGMP.

Insulin

11061-68-0sc-29062
sc-29062A
sc-29062B
100 mg
1 g
10 g
$153.00
$1224.00
$12239.00
82
(1)

Activates the PI3K/Akt pathway, which is involved in cell cycle regulation and could indirectly enhance CWF19L1's role in cell cycle control.

FTY720

162359-56-0sc-202161
sc-202161A
sc-202161B
1 mg
5 mg
25 mg
$32.00
$75.00
$118.00
14
(1)

A sphingosine 1-phosphate receptor modulator that can influence cell cycle-related pathways, possibly leading to enhanced CWF19L1 activity.

Rolipram

61413-54-5sc-3563
sc-3563A
5 mg
50 mg
$75.00
$212.00
18
(1)

Phosphodiesterase inhibitor that prevents cAMP breakdown, potentially increasing CWF19L1 activity through elevated cAMP levels affecting cell cycle control.

Dibutyryl-cAMP

16980-89-5sc-201567
sc-201567A
sc-201567B
sc-201567C
20 mg
100 mg
500 mg
10 g
$45.00
$130.00
$480.00
$4450.00
74
(7)

Cell-permeable cAMP analog that activates cAMP-dependent pathways, potentially leading to increased CWF19L1 activity in cell cycle control.

Lithium

7439-93-2sc-252954
50 g
$214.00
(0)

Inhibits GSK-3, leading to activation of Wnt signaling. This can indirectly influence CWF19L1 by affecting pathways involved in cell cycle regulation.